Catherine Novack
Stock Analyst at Jones Trading
(1.21)
# 3,718
Out of 5,055 analysts
22
Total ratings
22.22%
Success rate
-4.79%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Novack
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KRRO Korro Bio | Downgrades: Hold | n/a | $6.15 | - | 2 | Nov 14, 2025 | |
| AARD Aardvark Therapeutics | Initiates: Buy | $33 | $10.36 | +218.53% | 1 | Oct 1, 2025 | |
| DYN Dyne Therapeutics | Initiates: Buy | $30 | $20.24 | +48.22% | 1 | Jun 26, 2025 | |
| CAPR Capricor Therapeutics | Maintains: Buy | $40 → $29 | $5.69 | +409.67% | 2 | Jun 25, 2025 | |
| FEMY Femasys | Maintains: Buy | $10 → $6 | $0.80 | +653.48% | 2 | May 13, 2025 | |
| RLYB Rallybio | Downgrades: Hold | n/a | $0.62 | - | 1 | Apr 15, 2025 | |
| PVLA Palvella Therapeutics | Initiates: Buy | $45 | $81.64 | -44.88% | 1 | Mar 25, 2025 | |
| PRQR ProQR Therapeutics | Initiates: Buy | $11 | $2.05 | +436.59% | 1 | Feb 12, 2025 | |
| EQ Equillium | Downgrades: Hold | n/a | $1.05 | - | 1 | Nov 1, 2024 | |
| WVE Wave Life Sciences | Maintains: Buy | $12 → $16 | $7.15 | +123.78% | 2 | Sep 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $3.53 | +296.60% | 1 | Sep 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $13 | $1.81 | +618.23% | 2 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $10.22 | -2.15% | 1 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $3.14 | +599.75% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $6.22 | - | 2 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $160 | $0.72 | +22,116.05% | 1 | Jul 21, 2023 |
Korro Bio
Nov 14, 2025
Downgrades: Hold
Price Target: n/a
Current: $6.15
Upside: -
Aardvark Therapeutics
Oct 1, 2025
Initiates: Buy
Price Target: $33
Current: $10.36
Upside: +218.53%
Dyne Therapeutics
Jun 26, 2025
Initiates: Buy
Price Target: $30
Current: $20.24
Upside: +48.22%
Capricor Therapeutics
Jun 25, 2025
Maintains: Buy
Price Target: $40 → $29
Current: $5.69
Upside: +409.67%
Femasys
May 13, 2025
Maintains: Buy
Price Target: $10 → $6
Current: $0.80
Upside: +653.48%
Rallybio
Apr 15, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.62
Upside: -
Palvella Therapeutics
Mar 25, 2025
Initiates: Buy
Price Target: $45
Current: $81.64
Upside: -44.88%
ProQR Therapeutics
Feb 12, 2025
Initiates: Buy
Price Target: $11
Current: $2.05
Upside: +436.59%
Equillium
Nov 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $1.05
Upside: -
Wave Life Sciences
Sep 25, 2024
Maintains: Buy
Price Target: $12 → $16
Current: $7.15
Upside: +123.78%
Sep 12, 2024
Initiates: Buy
Price Target: $14
Current: $3.53
Upside: +296.60%
Aug 16, 2024
Maintains: Buy
Price Target: $5 → $13
Current: $1.81
Upside: +618.23%
Apr 18, 2024
Initiates: Buy
Price Target: $10
Current: $10.22
Upside: -2.15%
Feb 16, 2024
Initiates: Buy
Price Target: $22
Current: $3.14
Upside: +599.75%
Oct 5, 2023
Downgrades: Hold
Price Target: n/a
Current: $6.22
Upside: -
Jul 21, 2023
Initiates: Buy
Price Target: $160
Current: $0.72
Upside: +22,116.05%